PubRank

J Brice Weinberg

Author PubWeight™ 92.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002 3.21
2 Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007 3.13
3 A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002 2.69
4 Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009 2.46
5 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010 2.37
6 Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 2010 2.15
7 p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infect Immun 2005 1.93
8 The role of biomechanics and inflammation in cartilage injury and repair. Clin Orthop Relat Res 2004 1.89
9 Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis 2009 1.86
10 Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 2003 1.86
11 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
12 Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2010 1.79
13 Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia. Leuk Lymphoma 2011 1.51
14 CD38 variation as a prognostic factor in chronic lymphocytic leukemia. Leuk Lymphoma 2013 1.39
15 Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infect Immun 2005 1.37
16 Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcome. PLoS Pathog 2010 1.37
17 Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One 2012 1.35
18 Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 2004 1.35
19 Persistent nuclear factor-kappa B activation in Ucp2-/- mice leads to enhanced nitric oxide and inflammatory cytokine production. J Biol Chem 2005 1.31
20 Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification. Blood 2006 1.29
21 Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 2008 1.28
22 Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 2012 1.26
23 Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J Infect Dis 2008 1.26
24 Nitric-oxide synthase output state. Design and properties of nitric-oxide synthase oxygenase/FMN domain constructs. J Biol Chem 2006 1.22
25 Enhanced integrative repair of the porcine meniscus in vitro by inhibition of interleukin-1 or tumor necrosis factor alpha. Arthritis Rheum 2007 1.21
26 Regulation of matrix turnover in meniscal explants: role of mechanical stress, interleukin-1, and nitric oxide. J Appl Physiol (1985) 2003 1.20
27 SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target. Blood 2011 1.18
28 Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin Immunol 2006 1.11
29 Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus. Clin Orthop Relat Res 2008 1.11
30 Repair response of the inner and outer regions of the porcine meniscus in vitro. Am J Sports Med 2007 1.10
31 NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 2009 1.10
32 Intraprotein electron transfer in inducible nitric oxide synthase holoenzyme. J Biol Inorg Chem 2008 1.09
33 Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2010 1.09
34 Differential activation of nitric-oxide synthase isozymes by calmodulin-troponin C chimeras. J Biol Chem 2004 1.07
35 Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infect Immun 2006 1.07
36 Thermodynamics of oxidation-reduction reactions in mammalian nitric-oxide synthase isoforms. J Biol Chem 2004 1.06
37 Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro. J Orthop Res 2008 1.06
38 Influence of hypoxia and reoxygenation on cytokine-induced production of proinflammatory mediators in articular cartilage. Arthritis Rheum 2002 1.06
39 Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol 2010 1.05
40 The effects of cyclic mechanical strain and tumor necrosis factor alpha on the response of cells of the meniscus. Osteoarthritis Cartilage 2004 1.04
41 Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care 2014 1.04
42 Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism. Mol Med 2004 1.01
43 Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. J Rheumatol 2003 0.99
44 A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res 2009 0.98
45 Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia. J Infect Dis 2006 0.97
46 Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. Am J Trop Med Hyg 2007 0.93
47 The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds. Biomaterials 2012 0.92
48 Impaired systemic production of prostaglandin E2 in children with cerebral malaria. J Infect Dis 2005 0.92
49 Safety profile of L-arginine infusion in moderately severe falciparum malaria. PLoS One 2008 0.92
50 Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults. Infect Immun 2003 0.91
51 Statin use and need for therapy in chronic lymphocytic leukemia. Leuk Lymphoma 2010 0.90
52 Biaxial strain effects on cells from the inner and outer regions of the meniscus. Connect Tissue Res 2006 0.90
53 Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fertil Steril 2002 0.90
54 Influence of oxygen tension on interleukin 1-induced peroxynitrite formation and matrix turnover in articular cartilage. J Rheumatol 2007 0.87
55 Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am J Trop Med Hyg 2003 0.86
56 Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum Genet 2009 0.86
57 Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity. Infect Immun 2003 0.84
58 Regional differences in prostaglandin E2 and nitric oxide production in the knee meniscus in response to dynamic compression. Biochem Biophys Res Commun 2007 0.84
59 Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia. Infect Immun 2004 0.84
60 The influence of oxygen tension on the induction of nitric oxide and prostaglandin E2 by mechanical stress in articular cartilage. Osteoarthritis Cartilage 2005 0.82
61 Chronic lymphocytic leukemia in African Americans. Leuk Lymphoma 2012 0.82
62 Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans. J Infect Dis 2010 0.82
63 Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans. Blood 2012 0.81
64 A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults. Malar J 2010 0.81
65 Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 2013 0.80
66 Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol 2012 0.80
67 Monoclonal B cell lymphocytosis. Leuk Lymphoma 2010 0.80
68 Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies. Leuk Lymphoma 2013 0.79
69 Monoclonal B cell lymphocytosis: clinical and population perspectives. Cytometry B Clin Cytom 2010 0.78
70 Clinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia. PLoS One 2013 0.78
71 The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus. Curr Mol Med 2004 0.78
72 Immunologic aspects of monoclonal B-cell lymphocytosis. Immunol Res 2011 0.77
73 Increased plasma arginase activity in human sepsis: association with increased circulating neutrophils. Clin Chem Lab Med 2014 0.77
74 Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels. Leuk Res 2005 0.77
75 Systemic nitric oxide production in human malaria. II. Analysis of mononuclear cell nitric oxide synthase type 2 antigen expression. Methods Mol Med 2002 0.76
76 Immunoglobulin class switch recombination in chronic lymphocytic leukemia. Leuk Lymphoma 2011 0.76
77 CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant. Leuk Res 2008 0.76
78 Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL. Br J Haematol 2009 0.76
79 A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia. Am J Clin Pathol 2010 0.75